Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties - PubMed (original) (raw)
Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties
Janine Bilsborough et al. Immunology. 2003 Apr.
Abstract
Repetitive stimulation of naïve T cells by immature splenic dendritic cells (DC) can result in the differentiation of T-cell lines with regulatory properties. In the present study we identified a population of DC in the mucosae that exhibit the plasmacytoid phenotype, secrete interferon-alpha (IFN-alpha) following stimulation with oligodeoxynucleotides containing certain cytosine-phosphate-guanosine (CpG) motifs and can differentiate naïve T cells into cells that exhibit regulatory properties. Although these DC appear to be present in both spleen and mesenteric lymph nodes (MLN), only CpG-matured DC from the MLN (but not the spleen) were able to differentiate naïve T cells into T regulatory 1-like cells with regulatory properties. The activity of these DC failed to sustain robust T-cell proliferation and thereby enhanced the suppressive efficacy of CD4+ CD25+ T regulatory cells. These DC are the major CD8alpha+ DC population in the Peyer's patches (PP). Given their significant presence in mucosal tissue, we propose that these DC may provide a mechanistic basis for the homeostatic regulation in the gut by eliciting regulatory cell suppressor function and poorly supporting T helper cell proliferation at a site of high antigenic stimulation like the intestine.
Figures
Figure 1
Phenotypic diversity of plasmacytoid dendritic cells (DC) in tissues of Flt3-ligand (Flt3L)-treated mice. A single-cell suspension was prepared from the spleen, mesenteric lymph nodes (MLN), peripheral lymph nodes (PLN) and Peyer's patches (PP) of Flt3L-treated mice and stained with cell-surface marker antibodies. Region 1 [R1] and region 2 [R2] were selected based on the expression of CD8α and CD11c, where CD8α+ CD11chi cells are included in R1 and CD8α+ CD11clo cells are included in R2. These gates were used to determine the relative expression of B220, Class II, CD40, CD80, CD86 and CD19 for CD8α+ CD11chi (black histograms) and CD8α+ CD11clo (grey histograms) populations by mean fluorescence intensity (MFI). The isotype controls for each tissue type are represented by the dotted line. Gr-1 expression was determined in a separate experiment using the same gate settings. A total of 30 000 live, gated events were collected for each plot. Data are representative of three separate experiments.
Figure 2
Interferon-α (IFN-α) secretion by CD8α+ CD11chi and CD8α+ CD11clo dendritic cell (DC) populations. CD8α+ CD11chi and CD8α+ CD11clo DC populations were isolated from the spleen, mesenteric lymph nodes (MLN) and peripheral lymph nodes (PLN) by fluorescence-activated cell sorter (FACS) analysis and incubated for 18 hr with CpG (1 µg/ml). As CD8α+ CD11chi DC cannot be isolated from Peyer's patches (PP), CD8α+ CD11clo DC from the PP were compared with CD8α− CD11chi DC from the PP. Supernatants were collected and IFN-α levels were measured by enzyme-linked immunosorbent assay (ELISA). Data are representative of three separate experiments. Error bars represent the standard error of the mean of triplicate wells. _P_-values were calculated using the unpaired Student _t_-test. _P_-values of <0·05 were considered significant.
Figure 3
CD8+ plasmacytoid dendritic cells (pDC) are less efficient at inducing T helper cell proliferation than CD8+ non-pDC. Fresh CD8+ pDC and CD8+ non-pDC populations were isolated from the spleen (Sp), peripheral lymph nodes (PLN) and mesenteric lymph nodes (MLN) by fluorescence-activated cell sorter (FACS) analysis. As Peyer's patches (PP) do not have the CD8+ non-pDC population, we isolated the CD8+ pDC and CD8− DC populations for comparison. The different DC populations were cultured with freshly isolated CD4+ DO11.10 T-cell receptor (TCR) transgenic T helper cells at a ratio of 5 : 1 (T cells : DC), and ovalbumin (OVA) peptide was added at a final concentration of 375 n
m
. Cellular proliferation was assessed after 72 hr by [3H]thymidine incorporation (a). Interleukin (IL)-10 (b) and interferon-γ (IFN-γ) (c) protein levels in culture supernatants were assessed by Luminex analysis at 48- and 72 hr, respectively. Data are representative of three separate experiment and the error bars represent the standard deviation of quadruplicate wells. _P_-values were calculated using the unpaired Student's _t_-test. _P_-values of <0·05 were considered significant.
Figure 4
CD8+ plasmacytoid dendritic cells (pDC) favour T regulatory (Treg)-mediated suppression over T-cell proliferation. Fresh CD4+ CD25− T helper cells (black circles) and CD4+ CD25+ Treg cells (white circles) were isolated from DO11.10 T-cell receptor (TCR) transgenic animals. T helper and Treg cells were cultured together (grey circles) or alone and stimulated with ovalbumin (OVA) peptide-pulsed CD8+ non-pDC or CD8+ pDC derived from the spleen, mesenteric lymph nodes (MLN) or peripheral lymph nodes (PLN). For Peyer's patches (PP), OVA peptide-pulsed CD8+ pDC and myeloid DC were used as antigen-presenting cells (APC). Cellular proliferation was measured by [3H]thymidine incorporation. Data are representative of two separate experiments and the error bars represent the standard deviation of triplicate wells.
Figure 5
T regulatory (Treg) cell-mediated suppression is more robust at high T helper : Treg cell ratios when CD8+ plasmacytoid dendritic cells (pDC) are the antigen-presenting cells (APC). Fresh CD4+ CD25− T helper and CD4+ CD25+ Treg cells were isolated from DO11.10 T-cell receptor (TCR) transgenic animals. T helper and Treg cells were cultured either alone (black circles and white circles, respectively) or together (grey circles) at various Treg to T helper ratios and stimulated with ovalbumin (OVA) peptide-pulsed CD8+ non-pDC or CD8+ pDC derived from the spleen [panels (a) and (b), respectively] or mesenteric lymph nodes (MLN) [panels (c) and (d), respectively]. Cellular proliferation was measured by [3H]thymidine incorporation. Data are representative of two separate experiments and the error bars represent the standard deviation of triplicate wells.
Figure 6
CD8+ plasmacytoid dendritic cells (pDC) induce de novo differentiation of T regulatory 1 (Tr1)-like cells from naïve T cells. T-cell lines were generated by culturing CD25-depleted CD4+ T cells for 3 weeks with either CD8+ pDC or CD8+ non-pDC from mesenteric lymph nodes (MLN). T-cell lines were then assayed for regulatory T-cell activity, as measured by inhibition of T helper cell proliferation. Fresh CD4+ CD25− T helper cells were isolated from DO11.10 T-cell receptor (TCR) transgenic mice and stimulated with increasing concentrations of ovalbumin (OVA) peptide in the presence (grey circles) or absence (black circles) of in vitro cultured T-cell lines. Irradiated splenocytes (a) or lipopolysaccharide (LPS) blasts (b) were used as antigen-presenting cells (APC). T cells depleted of CD25+ cells at the onset of culture exhibited the ability to differentiate de novo into Tr1-like cells with suppressive activity following culture with CD8+ pDC. Data are representative of two separate experiments and the error bars represent the standard deviation of triplicate wells. *Statistical significance at P < 0·05; **statistical significance at P < 0·02 (Welch _t_-test). Statistical analysis was calculated at the 50 n
m
and 500 n
m
data points only.
Figure 7
Mesenteric lymph node (MLN) CD8+ plasmacytoid dendritic cells (pDC) activated with CpG maintain the ability to induce T regulatory 1 (Tr1)-like T cells that exhibit regulatory T-cell function. T-cell lines were cultured with CD8+ pDC or CD8+ non-pDC for 4 weeks prior to assaying for regulatory T-cell activity. MLN CD8+ pDC and CD8+ non-pDC were incubated for 18 hr with CpG before co-culture with T-cell lines. Levels of CD80, CD86 and CD40, expressed by CD8+ pDC following an 18-hr incubation in the presence or absence of CpG, were assessed by fluorescence-activated cell sorter (FACS) analysis (a). Regulatory activity was assessed by the ability of the Tr1-like cell lines to inhibit the proliferation of freshly isolated ovalbumin (OVA) T-cell receptor (TCR) transgenic CD4+ CD25− T helper cells stimulated with 500 n
m
of OVA peptide in the presence (grey bars) or in the absence (black bars) of _in vitro_-differentiated regulatory Tr1-like cell lines (b). Lipopolysaccharide (LPS) blasts (left panel) or irradiated splenocytes (right panel) were used as antigen-presenting cells (APC) (b). T-cell lines generated by stimulation with CpG-matured CD8+ pDC secrete higher levels of interleukin (IL)-4 and IL-10 following stimulation with plate-bound anti-CD3 compared with T-cell lines generated by stimulation with CpG-matured CD8+ non-pDC (c). Data are representative of three separate experiments and the error bars represent the standard deviation of triplicate wells. _P_-values were calculated using the unpaired Student's _t_-test. _P_-values of <0·05 were considered significant.
Similar articles
- In vivo enhancement of dendritic cell function.
Bilsborough J, Viney JL. Bilsborough J, et al. Ann N Y Acad Sci. 2004 Dec;1029:83-7. doi: 10.1196/annals.1309.011. Ann N Y Acad Sci. 2004. PMID: 15681747 Review. - Functional maturation of lamina propria dendritic cells by activation of NKT cells mediates the abrogation of oral tolerance.
Chang JH, Lee JM, Youn HJ, Lee KA, Chung Y, Lee AY, Kweon MN, Kim HY, Taniguchi M, Kang CY. Chang JH, et al. Eur J Immunol. 2008 Oct;38(10):2727-39. doi: 10.1002/eji.200838159. Eur J Immunol. 2008. PMID: 18825753 - Dendritic cells from Peyer's patches and mesenteric lymph nodes differ from spleen dendritic cells in their response to commensal gut bacteria.
Fink LN, Frøkiaer H. Fink LN, et al. Scand J Immunol. 2008 Sep;68(3):270-9. doi: 10.1111/j.1365-3083.2008.02136.x. Epub 2008 Jun 19. Scand J Immunol. 2008. PMID: 18565117 - Development of the dendritic cell system during mouse ontogeny.
Dakic A, Shao QX, D'Amico A, O'Keeffe M, Chen WF, Shortman K, Wu L. Dakic A, et al. J Immunol. 2004 Jan 15;172(2):1018-27. doi: 10.4049/jimmunol.172.2.1018. J Immunol. 2004. PMID: 14707075 - Re-thinking the functions of IgA(+) plasma cells.
Gommerman JL, Rojas OL, Fritz JH. Gommerman JL, et al. Gut Microbes. 2014;5(5):652-62. doi: 10.4161/19490976.2014.969977. Gut Microbes. 2014. PMID: 25483334 Free PMC article. Review.
Cited by
- Commensal bacteria promote type I interferon signaling to maintain immune tolerance in mice.
Vasquez Ayala A, Hsu CY, Oles RE, Matsuo K, Loomis LR, Buzun E, Carrillo Terrazas M, Gerner RR, Lu HH, Kim S, Zhang Z, Park JH, Rivaud P, Thomson M, Lu LF, Min B, Chu H. Vasquez Ayala A, et al. J Exp Med. 2024 Jan 1;221(1):e20230063. doi: 10.1084/jem.20230063. Epub 2023 Dec 12. J Exp Med. 2024. PMID: 38085267 Free PMC article. - Current perspective on biological properties of plasmacytoid dendritic cells and dysfunction in gut.
Guo X, He C, Xin S, Gao H, Wang B, Liu X, Zhang S, Gong F, Yu X, Pan L, Sun F, Xu J. Guo X, et al. Immun Inflamm Dis. 2023 Sep;11(9):e1005. doi: 10.1002/iid3.1005. Immun Inflamm Dis. 2023. PMID: 37773693 Free PMC article. Review. - Retinoic Acid-Containing Liposomes for the Induction of Antigen-Specific Regulatory T Cells as a Treatment for Autoimmune Diseases.
Ter Braake D, Benne N, Lau CYJ, Mastrobattista E, Broere F. Ter Braake D, et al. Pharmaceutics. 2021 Nov 17;13(11):1949. doi: 10.3390/pharmaceutics13111949. Pharmaceutics. 2021. PMID: 34834364 Free PMC article. - Plasmacytoid dendritic cells in the eye.
Jamali A, Kenyon B, Ortiz G, Abou-Slaybi A, Sendra VG, Harris DL, Hamrah P. Jamali A, et al. Prog Retin Eye Res. 2021 Jan;80:100877. doi: 10.1016/j.preteyeres.2020.100877. Epub 2020 Jul 24. Prog Retin Eye Res. 2021. PMID: 32717378 Free PMC article. Review. - Resident plasmacytoid dendritic cells patrol vessels in the naïve limbus and conjunctiva.
Jamali A, Harris DL, Blanco T, Lopez MJ, Hamrah P. Jamali A, et al. Ocul Surf. 2020 Apr;18(2):277-285. doi: 10.1016/j.jtos.2020.02.005. Epub 2020 Feb 25. Ocul Surf. 2020. PMID: 32109562 Free PMC article.
References
- Shortman K, Caux C. Dendritic cell development: multiple pathways to nature's adjuvants. Stem Cells. 1997;15:409–19. - PubMed
- Vremec D, Shortman K. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J Immunol. 1997;159:565–73. - PubMed
- Kronin V, Winkel K, Suss G, Kelso A, Heath W, Kirberg J, von Boehmer H, Shortman K. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J Immunol. 1996;157:3819–27. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous